Acuta Capital Partners’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,316,268
| Closed | -$7.9M | – | 43 |
|
|
2021
Q3 | $7.9M | Hold |
1,316,268
| – | – | 2.79% | 10 |
|
|
2021
Q2 | $6.41M | Sell |
1,316,268
-297,732
| -18% | -$1.45M | 2.56% | 12 |
|
|
2021
Q1 | $3.99M | Buy |
1,614,000
+364,000
| +29% | +$899K | 1.44% | 30 |
|
|
2020
Q4 | $3.43M | Buy |
1,250,000
+635,000
| +103% | +$1.74M | 0.93% | 36 |
|
|
2020
Q3 | $947K | Buy |
+615,000
| New | +$947K | 0.26% | 41 |
|
|
2017
Q2 | – | Sell |
-175,000
| Closed | -$1.39M | – | 38 |
|
|
2017
Q1 | $1.39M | Hold |
175,000
| – | – | 0.33% | 31 |
|
|
2016
Q4 | $1.57M | Buy |
+175,000
| New | +$1.57M | 0.58% | 27 |
|